Risk Factors for Malignancy of Pheochromocytoma and Abdominal Paraganglioma in Children: Clinicopathologic Perspectives

[1]  N. Ngo,et al.  Immunohistochemical markers of the hypoxic response can identify malignancy in phaeochromocytomas and paragangliomas and optimize the detection of tumours with VHL germline mutations , 2012, British Journal of Cancer.

[2]  Lei Feng,et al.  Clinical risk factors for malignancy and overall survival in patients with pheochromocytomas and sympathetic paragangliomas: primary tumor size and primary tumor location as prognostic indicators. , 2011, The Journal of clinical endocrinology and metabolism.

[3]  N. Perrier,et al.  A current review of the etiology, diagnosis, and treatment of pediatric pheochromocytoma and paraganglioma. , 2010, The Journal of clinical endocrinology and metabolism.

[4]  A. Tischler.  Pheochromocytoma and extra-adrenal paraganglioma: updates. , 2009, Archives of pathology & laboratory medicine.

[5]  A. Vénisse,et al.  The succinate dehydrogenase genetic testing in a large prospective series of patients with paragangliomas. , 2009, The Journal of clinical endocrinology and metabolism.

[6]  A. Tischler,et al.  Observer Variation in the Application of the Pheochromocytoma of the Adrenal Gland Scaled Score , 2009, The American journal of surgical pathology.

[7]  Laura H. Tang,et al.  Prognostic indicators of malignancy in adrenal pheochromocytomas: clinical, histopathologic, and cell cycle/apoptosis gene expression analysis. , 2008, Surgery.

[8]  G. Stamp,et al.  Expression of HIF-1α, HIF-2α (EPAS1), and Their Target Genes in Paraganglioma and Pheochromocytoma with VHL and SDH Mutations , 2006 .

[9]  W. Young,et al.  Pheochromocytoma and Paraganglioma in Children: A Review of Medical and Surgical Management at a Tertiary Care Center , 2006, Pediatrics.

[10]  G. Eisenhofer,et al.  Pheochromocytoma: Diagnosis and management update , 2004, Current hypertension reports.

[11]  David I. Smith,et al.  Malignant pheochromocytoma: current status and initiatives for future progress. , 2004, Endocrine-related cancer.

[12]  R. Hinze,et al.  CGH and CD 44/MIB-1 immunohistochemistry are helpful to distinguish metastasized from nonmetastasized sporadic pheochromocytomas , 2004, Modern Pathology.

[13]  P. Rustin,et al.  Mutations in the SDHB gene are associated with extra-adrenal and/or malignant phaeochromocytomas. , 2003, Cancer research.

[14]  C. Larsson,et al.  KI-67 AND hTERT Expression Can Aid in the Distinction between Malignant and Benign Pheochromocytoma and Paraganglioma , 2003, Modern Pathology.

[15]  L. Thompson.  Pheochromocytoma of the Adrenal Gland Scaled Score (PASS) to Separate Benign From Malignant Neoplasms: A Clinicopathologic and Immunophenotypic Study of 100 Cases , 2002, The American journal of surgical pathology.

[16]  C. Cordon-Cardo,et al.  Adrenocortical carcinoma: clinical, morphologic, and molecular characterization. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[17]  J. Luk,et al.  The clinicopathological features and importance of p53, Rb, and mdm2 expression in phaeochromocytomas and paragangliomas , 2001, Journal of clinical pathology.

[18]  W. Neblett,et al.  Twenty-Five-Year Surgical Experience with Pheochromocytoma in Children , 2000, The American surgeon.

[19]  K. Omata,et al.  Immunohistochemical estimations of growth activity to predict biological behavior of pheochromocytomas. , 1999, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[20]  H. Bruining,et al.  Prognostic value of p53, bcl‐2, and c‐erbB‐2 protein expression in phaeochromocytomas , 1999, The Journal of pathology.

[21]  Y. Révillon,et al.  Pheochromocytoma and paraganglioma in children: a report of 24 cases of the French Society of Pediatric Oncology. , 1997, Pediatric hematology and oncology.

[22]  H Stein,et al.  Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. , 1984, Journal of immunology.

[23]  J. Balfe,et al.  Pediatric pheochromocytoma , 2005, Pediatric Surgery International.

[24]  R. DeLellis.  Pathology and genetics of tumours of endocrine organs , 2004 .

[25]  A. McNichol.  Differential diagnosis of pheochromocytomas and paragangliomas. , 2001, Endocrine pathology.

[26]  McNichol Am.  Differential diagnosis of pheochromocytomas and paragangliomas. , 2001 .

[27]  Lippincott Williams Wilkins,et al.  The American journal of surgical pathology , 1977 .